Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer

被引:28
作者
Li, Faping [1 ]
Guo, Hui [1 ]
Qiu, Heping [1 ]
Liu, Shukun [1 ]
Wang, Kaixuan [1 ]
Yang, Chao [1 ]
Tang, Chao [1 ]
Zheng, Qi [1 ]
Hou, Yuchuan [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Urol, Changchun 130021, Jilin, Peoples R China
关键词
cervical cancer; radiation cystitis; radiotherapy; ureteral obstruction; urological complications; BRACHYTHERAPY; BLADDER; WOMEN;
D O I
10.1097/MD.0000000000010173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Radiotherapy is a reliable method to cure cervical cancer patients, but it could cause serious urological complications after the treatment due to the anatomical location of the cervix. The main purpose of this retrospective analysis is to study the incidence, latency, and therapeutic efficacy of urological complications caused by radical hysterectomy with postoperative radiotherapy or radiotherapy alone in patients with cervical cancer.A retrospective analysis was conducted on patients with cervical cancer who received radical hysterectomy with postoperative radiotherapy or radiotherapy alone at the First Hospital of Jilin University between January 2010 and May 2016. The urological complications were confirmed by clinical manifestation, ultrasound, computed tomography (CT), nuclear scintigraphy, and assessment of renal function. All the patients with urological complications received conventional treatment, including conservative, electrosurgery, ureteral stents, nephrectomy, and neoplasty. The onset time of radiation injury symptoms was confirmed according to the medical history and follow-up. The surveillance for the therapeutic effects for these complications was accomplished by cystoscopy, imaging, and laboratory assessment.The overall rate of urological complications after treatment was 3.26%, comprising 2.12% ureteral obstruction, 0.98% radiocystitis, and 0.16% vesicovaginal fistula. The incidence of ureteral obstruction in patients treated with radical hysterectomy with postoperative radiotherapy and radiotherapy alone was not statistically significant (2.18% vs 1.59%, P>.05). The median onset time of radiocystitis and ureteral obstruction was 10 months (0-75 months) and 12 months (2-66.3 months), respectively. The onset time of vesicovaginal fistula was 3.5 months. After the appropriate treatment, the majority of the complications were under control.The incidence of urological complications is acceptable. There was no statistical difference in the risk between patients treated with radical hysterectomy with postoperative radiotherapy and radiotherapy alone. The latency period between radiotherapy and the manifestation of urological complications may be relatively long. So it is crucial to underline long-term follow-up after radiotherapy. The majority of urological complications were alleviated after symptomatic treatment and the patients with cervical cancer achieved long-term remissions or cures.
引用
收藏
页数:5
相关论文
共 22 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] [Anonymous], 2017, CA-CANCER J CLIN, V67, P7
  • [3] COMPLICATIONS AFTER RADIATION-THERAPY FOR CERVICAL CARCINOMA
    BOSCH, A
    FRIAS, Z
    [J]. ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1977, 16 (01): : 53 - 62
  • [4] Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer
    Brar, Harinder
    Hogen, Liat
    Covens, Al
    [J]. CANCER, 2017, 123 (10) : 1751 - 1759
  • [5] Second cancers among 104,760 survivors of cervical cancer:: Evaluation of long-term risk
    Chaturvedi, Anil K.
    Engels, Eric A.
    Gilbert, Ethel S.
    Chen, Bingshu E.
    Storm, Hans
    Lynch, Charles F.
    Hall, Per
    Langmark, Froydis
    Pukkala, Eero
    Kaijser, Magnus
    Andersson, Michael
    Fossa, Sophie D.
    Joensuu, Heikki
    Boice, John D.
    Kleinerman, Ruth A.
    Travis, Lois B.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (21): : 1634 - 1643
  • [6] Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer
    Elliott, Sean P.
    Fan, Yunhua
    Jarosek, Stephanie
    Chu, Haitao
    Downs, Levi
    Dusenbery, Kathryn
    Geller, Melissa A.
    Virnig, Beth A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (03): : 586 - 593
  • [7] Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma
    Gellrich, J
    Hakenberg, OW
    Oehlschläger, S
    Wirth, MR
    [J]. ONKOLOGIE, 2003, 26 (04): : 334 - 340
  • [8] Georg P, 2013, STRAHLENTHER ONKOL, V189, P535, DOI 10.1007/s00066-013-0365-7
  • [9] Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base
    Hague, Waciar
    Verma, Vivek
    Fakhreddine, Mohamad
    Hatch, Sandra
    Butler, E. Brian
    Teh, Bin S.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 144 (01) : 28 - 33
  • [10] Cervical Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines
    Koh, Wui-Jin
    Greer, Benjamin E.
    Abu-Rustum, Nadeem R.
    Apte, Sachin M.
    Campos, Susana M.
    Cho, Kathleen R.
    Chu, Christina
    Cohn, David
    Crispens, Marta Ann
    Dorigo, Oliver
    Eifel, Patricia J.
    Fisher, Christine M.
    Frederick, Peter
    Gaffney, David K.
    Han, Ernest
    Huh, Warner K.
    Lurain, John R., III
    Mutch, David
    Fader, Amanda Nickles
    Remmenga, Steven W.
    Reynolds, R. Kevin
    Teng, Nelson
    Tillmanns, Todd
    Valea, Fidel A.
    Yashar, Catheryn M.
    McMillian, Nicole R.
    Scavone, Jillian L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (04): : 395 - 404